Skip to main content
OLIPASS CORPORATION logo

OLIPASS CORPORATION — Investor Relations & Filings

Ticker · 244460 ISIN · KR7244460002 KO Professional, scientific and technical activities
Open in API
Filings indexed 507 across all filing types
Latest filing 2023-09-05 Director's Dealing
Country KR South Korea
Listing KO 244460

About OLIPASS CORPORATION

https://www.olipass.com/front/eng/index…

OLIPASS CORPORATION is a research and development company focused on creating RNA therapeutics. The company's core activities are centered on its proprietary OliPass Peptide Nucleic Acid (OPNA) platform. OPNA is a novel technology derived from Peptide Nucleic Acid (PNA) by introducing a cationic lipid moiety onto the nucleobase. This structural modification is designed to markedly improve cell permeability, a key challenge in nucleic acid-based drug delivery. The platform is optimized to induce exon skipping by specifically binding to target pre-mRNA inside the cell nucleus, enabling the discovery and development of new therapeutic candidates.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose their personal shareholdings and changes therein, which corresponds to the 'Director's Dealing' category.
2023-09-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special relations (insiders). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-09-05 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the issuance of convertible bonds (전환사채권 발행결정). This document details the terms of the financing, including interest rates, conversion prices, and the use of proceeds. It falls under the category of capital and financing updates as it describes a specific corporate fundraising activity.
2023-09-04 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Olipass Co., Ltd. regarding a decision for a third-party capital increase (유상증자결정). It details the issuance of new shares, the purpose of the funds, the conversion terms for preferred shares, and the list of third-party assignees. This is a formal regulatory filing concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-09-04 Korean
투자판단관련주요경영사항(호흡기질환 바이러스 치료제 개발을 위한 기술이전 및 연구개발 협력 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Olipass) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically detailing a technology transfer and R&D cooperation agreement. Since this is a formal announcement of a significant business transaction/contract that does not fit into specific categories like M&A (which usually implies a takeover or merger) or other specialized categories, it falls under the general regulatory filing category.
2023-08-22 Korean
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (Olipass) regarding the confirmation of audit opinions and financial status (specifically capital impairment). It provides specific financial data for the semi-annual period ending 2023-06-30. Since it is a formal regulatory disclosure of financial results and audit status, it falls under the category of general regulatory filings. H1 2023
2023-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.